Add to ORKGSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is rarely fatal in children and young people (CYP, <18 years old), but quantifying the risk of death is challenging because CYP are often infected with SARS-CoV-2 exhibiting no or minimal symptoms. To distinguish between CYP who died as a result of SARS-CoV-2 infection and those who died of another cause but were coincidentally infected with the virus, we undertook a clinical review of all CYP deaths with a positive SARS-CoV-2 test from March 2020 to February 2021. The predominant SARS-CoV-2 variants were wild-type and Alpha. Here we show that, of 12,023,568 CYP living in England, 3,105 died, including 61 who were positive for SARS-CoV-2. Of these deaths, 25 were due to ...
Objectives: We aimed to prospectively describe the incidence and clinical spectrum of SARS-CoV-2 inf...
OBJECTIVES: To assess disease trends, testing practices, community surveillance, case-fatality and e...
BACKGROUND: Children with cancer are frequently immunocompromised. While children are generally thou...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is rarely fatal in children a...
BackgroundWe aimed to describe pre-existing factors associated with severe disease, primarily admiss...
Identifying which children and young people (CYP) are most vulnerable to serious infection due to se...
BACKGROUND: There have been no population-based studies of SARS-CoV-2 testing, PCR-confirmed infecti...
Background: There have been no population-based studies of SARS-CoV-2 testing, PCR-confirmed infe...
We hypothesised that the clinical characteristics of hospitalised children and young people (CYP) wi...
BACKGROUND: We hypothesised that the clinical characteristics of hospitalised children and young peo...
Objectives Using the National Child Mortality Database (NCMD), this work aims to investigate and qua...
Objectives Using the National Child Mortality Database (NCMD), this work aims to investigate and qua...
INTRODUCTION: SARS-CoV-2 infection rarely causes hospitalisation in children and young people (CYP),...
Objectives: We aimed to prospectively describe the incidence and clinical spectrum of SARS-CoV-2 inf...
OBJECTIVES: To assess disease trends, testing practices, community surveillance, case-fatality and e...
BACKGROUND: Children with cancer are frequently immunocompromised. While children are generally thou...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is rarely fatal in children a...
BackgroundWe aimed to describe pre-existing factors associated with severe disease, primarily admiss...
Identifying which children and young people (CYP) are most vulnerable to serious infection due to se...
BACKGROUND: There have been no population-based studies of SARS-CoV-2 testing, PCR-confirmed infecti...
Background: There have been no population-based studies of SARS-CoV-2 testing, PCR-confirmed infe...
We hypothesised that the clinical characteristics of hospitalised children and young people (CYP) wi...
BACKGROUND: We hypothesised that the clinical characteristics of hospitalised children and young peo...
Objectives Using the National Child Mortality Database (NCMD), this work aims to investigate and qua...
Objectives Using the National Child Mortality Database (NCMD), this work aims to investigate and qua...
INTRODUCTION: SARS-CoV-2 infection rarely causes hospitalisation in children and young people (CYP),...
Objectives: We aimed to prospectively describe the incidence and clinical spectrum of SARS-CoV-2 inf...
OBJECTIVES: To assess disease trends, testing practices, community surveillance, case-fatality and e...
BACKGROUND: Children with cancer are frequently immunocompromised. While children are generally thou...